Upjohn

出自Local Chinese Wikipedia
跳至導覽 跳至搜尋
The Upjohn Company
公司結局Pharmacia合併為Pharmacia & Upjohn
後繼機構Pharmacia & Upjohn
暉致(Viatris)
成立1886年 (1886)
結束1995年,​31年前​(1995
總部美國密歇根州波蒂奇
產業製藥產業
File:Upjohn's Friable Pills.jpg
Upjohn的早期Logo

Upjohn是一家美國製藥公司,1886年由威廉·E·厄普約翰密歇根州黑斯廷斯成立[1],1995年與瑞典Pharmacia公司合併為Pharmacia & Upjohn,現為輝瑞公司所有。

歷史[編輯]

1976年,公司的三位科學家開發了Upjohn雙羥基化反應[2]

產品[編輯]

四位數[編輯]

名稱 CAS號 分子式 化學結構
苄非他明
(U-0441)
156-08-1 C
17
H
21
N
File:Benzphetamine.svg
U-0882 310-35-0 C
18
H
21
NO
2
File:U-0882.svg
敵鼠
(U-1363)
82-66-6 C
23
H
16
O
3
File:Diphenadione.svg
羧雌醚
(U-2911)
1755-52-8 C
17
H
22
O
3
File:Carbestrol.svg
U-4527 66-81-9 C
15
H
23
NO
4
File:Cycloheximide.svg
U-5956 480-49-9 C
35
H
58
O
11
File:FilipinIII.png
U-6040 76-43-7 C
20
H
29
FO
3
File:Fluoxymesterone.svg
U-6056 13117-35-6 C
13
H
18
N
2
File:Dimethylhomotryptamine.svg
U-8113 1688-71-7 C
10
H
13
NO
File:U-8113.svg
U-8344 66-75-1 C
8
H
11
Cl
2
N
3
O
2
File:Uramustine.svg
U-8471 2668-66-8 C
22
H
32
O
3
File:Medrysone.svg
U-8614 426-13-1 C
22
H
29
FO
4
File:Fluorometholone.svg
醋酸甲羥孕酮
(U-8839)
71-58-9 C
24
H
34
O
4
File:Medroxyprogesterone acetate.svg
U-8840 520-85-4 C
22
H
32
O
3
File:Medroxyprogesterone.svg
2-氨基-1,1,3-三氰基-1-丙烯
(U-9189)
868-54-2 C
6
H
4
N
4
File:Tricyanoaminopropene.svg
U-9889 18883-66-4 C
8
H
15
N
3
O
7
File:Streptozocin.svg

五位數[編輯]

名稱 CAS號 分子式 化學結構
林可黴素
(U-10149)
154-21-2 C
18
H
34
N
2
O
6
S
File:Lincomycin.png
U-10157 705-62-4 C
9
H
12
N
2
S
米勃龍
(U-10997)[3]
3704-09-4 C
20
H
30
O
2
File:Mibolerone structure.png
U-11000A 1845-11-0 C
29
H
31
NO
2
File:Nafoxidine.svg
U-11555A 64-96-0 C
28
H
31
NO
2
File:U-11,555 image.png
曲托龍
(U-11828)[3]
3764-87-2 C
19
H
28
O
2
File:Trestolone structure.svg
U-12504 1228-19-9 C
13
H
18
ClN
3
O
3
S
File:Glypinamide.svg
U-17312E 2235-90-7 C
12
H
16
N
2
File:AET.svg
U-17323 3801-06-7 C
24
H
31
FO
5
File:Fluorometholone acetate.svg
U-17835 1156-19-0 C
14
H
21
N
3
O
3
S
File:Tolazamide.svg
布洛芬
(U-18573)
15687-27-1 C
13
H
18
O
2
File:Ibuprofen.svg
勃拉睾酮
(U-19763)
1605-89-6 C
21
H
32
O
2
File:Bolasterone.png
Module:WikidataLink第216行Lua錯誤:attempt to call field 'entityExists' (a nil value)
(U-22020)
5034-76-4 C
22
H
19
NO
2
File:Indoxole.svg
PNU-22394
(U-22394A)
15923-78-1 C
13
H
16
N
2
File:PNU-22394.svg
U-22410A 10090-61-6 C
28
H
29
NO
File:U-22,410A.svg
卡魯睾酮
(U-22550)
17021-26-0 C
21
H
32
O
2
File:Calusterone.svg
U-23284 18771-50-1 C
9
H
16
N
2
O
6
File:Tetrahydrouridine.svg
U-23469[4] 36840-93-4 C
26
H
28
O
4
File:U-23,469.svg
U-24568 21766-17-6 C
26
H
22
N
2
O
2
File:U-24,568.svg
U-26597A 8001-95-4 C
11
H
28
ClN
5
O
File:Colestipol constituents.png
U-28288D 22195-34-2 C
10
H
19
N
3
O
2
File:Guanadrel.svg
2-MDP英語2-MDP
(U-23807A)
33887-05-7 C
16
H
19
NO
File:2-MDP.svg
U-28774 27223-35-4 C
20
H
17
ClN
2
O
3
File:Ketazolam.svg
U-29409 31785-60-1 C
18
H
14
N
2
O
File:U-29409.svg
U-30870 50303-11-2 C
23
H
31
NO
2
File:U-30870.svg
U-31355 99983-92-3 C
11
H
10
ClN
3
S
File:U-31,355.svg
阿普唑侖
(U-31889)
28981-97-7 C
17
H
13
ClN
4
File:Alprazolam structure.svg
骨化二醇
(U-32070)
19356-17-3 C
27
H
44
O
2
File:Calcidiol2.svg
U-32802A 36735-48-5 C
22
H
23
F
2
NO
File:U-32,802A.svg
三唑侖
(U-33030)
28911-01-5 C
17
H
12
Cl
2
N
4
File:Triazolam.svg
U-35777A 55199-71-8 C
23
H
27
F
2
NO
2
File:U-35,777A.svg
U-37883A 57568-80-6 C
21
H
35
N
3
O
File:U-37883A.svg
U-41792 56714-70-6 C
21
H
29
NO
File:U-41792.svg
U-42585 53882-12-5 C
11
H
6
ClN
3
O
6
File:Lodoxamide.svg
U-46619 56985-40-1 C
21
H
34
O
4
File:U-46619.svg
U-46785 61263-35-2 C
23
H
38
O
4
File:Meteneprost.svg
U-47109 67579-13-9 C
15
H
20
Cl
2
N
2
O
File:U-47109 structure.png
U-47476A 36192-18-4 C
12
H
18
N
2
File:U-47,476A.svg
U-47700 82657-23-6 C
16
H
22
Cl
2
N
2
O
File:U-47700 fixedstructure.svg
溴朵林
(U-47931E)
67579-24-2 C15H21BrN2O File:U-47931E structure.png
U-48520 67579-11-7 C
16
H
23
ClN
2
O
File:U-48520 structure.png
依氯那明
(U-48753)
67450-44-6 C
16
H
22
Cl
2
N
2
O
File:Eclanamine.svg
U-48800 2370977-17-4 C
17
H
24
Cl
2
N
2
O
File:U-48800 structure.png
U-49900 67579-76-4 C
18
H
26
Cl
2
N
2
O
File:U-49900 structure.png
U-50211 98587-47-4 C
16
H
24
N
2
O
2
File:U-50211 structure.png
U-50488 67198-13-4 C
19
H
26
Cl
2
N
2
O
File:U-50488 structure.svg
U-51574 PubChem CID:44269303 C
17
H
24
Cl
2
N
2
O
File:U-51574 structure.png
U-52047 71628-96-1 C
28
H
31
NO
10
File:Menogaril.png
U-53059 70529-35-0 C
18
H
14
F
3
NO
2
S
File:Itazigrel.svg
U-54669F 72141-57-2 C
27
H
22
F
4
N
4
O
3
S
File:Losulazine.svg
U-57700 102092-12-6 C
16
H
21
N
File:(Z)-Tazadolene.svg
U-57930E 79548-73-5 C
17
H
31
ClN
2
O
5
S
File:Pirlimycin structure.svg
U-58838 83701-22-8 C
9
H
15
N
5
O
4
S
File:Minoxidil sulfate.svg
Lua錯誤:attempt to call field 'entityExists' (a nil value)。
(U-60257)
79672-88-1 C
26
H
35
NO
4
File:Piriprost.svg
U-61431F 81845-44-5 C
22
H
36
O
4
File:Ciprostene.svg
螺朵林英語Spiradoline
(U-62066)
87151-85-7 C
22
H
30
Cl
2
N
2
O
2
File:Spiradoline Structure.svg
U-63557A 85666-24-6 C
15
H
11
NO
3
File:Furegrelate.svg
U-64279E 104010-37-9 C
19
H
17
N
5
O
7
S
3
File:Ceftiofur.png
阿侖替莫
(U-66444B)
112892-81-6 C
19
H
25
NO
File:Alentemol.svg
U-69167 99499-40-8 C
16
H
17
N
3
OS
2
File:Disuprazole.svg
U-69593 96744-75-1 C
22
H
32
N
2
O
2
File:U-69,593 structure.svg
U-73122 112648-68-7 C
29
H
40
N
2
O
3
File:U-73122.svg
U-73343 142878-12-4 C
29
H
42
N
2
O
3
File:U-73343.svg
U-74006 110101-66-1 C
38
H
52
N
6
O
2
File:Tirilazad.svg
Module:WikidataLink第216行Lua錯誤:attempt to call field 'entityExists' (a nil value) 119477-85-9 C
22
H
33
NO
3
U-75875
(Pnu-75875)
112190-24-6 C
45
H
61
N
7
O
7
File:U-75875.svg
U-77891 119878-31-8 C
18
H
24
Br
2
N
2
O
File:U-77891.svg
U-78036 123742-98-3 C
17
H
11
ClN
2
O
File:U-78036.svg
U-78875 124423-84-3 C
18
H
17
N
5
O
2
File:Panadiplon.svg
Module:WikidataLink第216行Lua錯誤:attempt to call field 'entityExists' (a nil value)
(U-80244)
119813-10-4 C
41
H
37
ClN
6
O
5
File:Carzelesin.svg
U-80493 136816-67-6 C
21
H
30
N
4
O
File:U-80493.svg
U-81749 126103-94-4 C
33
H
56
N
4
O
4
File:U-81749.svg
U-82208E 136591-56-5 C
20
H
36
N
2
O
3
S
U-82209E 136591-58-7 C
20
H
36
N
2
O
3
S
U-84569 130736-25-3 C
25
H
23
NO
4
File:U-84569.svg
U-86983 130736-65-1 C
19
H
18
N
2
O
4
File:U-86983.svg
阿替韋啶
(U-87201E)
138540-32-6 C
21
H
25
N
5
O
2
File:Atevirdine structure.svg
U-88779E 149539-01-5 C
29
H
33
ClN
2
O
2
File:U-88779E.svg
U88999E 142223-57-2 C
29
H
32
F
2
N
2
O
2
File:U88999E.svg
U-89360E 161897-65-0 C
28
H
52
N
8
O
6
File:U-89360E.svg
U-90152 136817-59-9 C
22
H
28
N
6
O
3
S
File:Delavirdine.svg
PNU-91356A
(U-91356)
152886-85-6 C
13
H
17
N
3
O
File:PNU91356A structure.png
U-92032 142223-92-5 C
30
H
35
F
2
N
3
O
2
File:U-92032.svg
U-92798 PC9891838 C
30
H
34
F
2
N
2
O
2
File:U92798.svg
U-96988 149394-65-0 C
24
H
26
O
3
File:U-96988.svg
普拉克索
(U-98528E)
104632-26-0 C
10
H
17
N
3
S
File:Pramipexole.svg
JPC-211英語PNU-99,194
(U-99194)
82668-33-5 C
17
H
27
NO
2
File:PNU-99194A-structure.png
U-99363 179556-82-2 C
20
H
27
N
3
O
File:U-99363.svg

六位數[編輯]

名稱 CAS號 分子式 化學結構
U-100480 168828-58-8 C
16
H
20
FN
3
O
3
S
File:Sutezolid structure.svg
U-101387 170858-33-0 C
21
H
27
N
3
O
3
S
File:Sonepiprazole.svg
U-101958 170856-57-2 C
21
H
29
N
3
O
File:U-101958.svg
U-103017 166335-18-8 C
28
H
28
N
2
O
5
S
File:Pnu-103017.svg

參考文獻[編輯]

  1. Lohrstorfer, Martha; Larson, Catherine. William E. Upjohn: Person of the Century 1853 - 1932. Kalamazoo Public Library. 2002 [December 24, 2024]. (原始內容存檔於May 17, 2008). Known by his contemporaries as a dreamer and a tinkerer, Dr. Upjohn saw a need to improve the means of administering medicine. Most medicines of the day were in fluid form, and those in pill form were often hard and insoluble. Patients were left to try to digest the bitter medicine, with no guarantee that it would dissolve in their systems effectively. Dr. Upjohn began experimenting with making better pills in the attic of his home. Eventually he invented his "friable" pill. Friable meant that the pill could easily be crushed to a powder. The pill was patented in 1885, and its reputation quickly spread within the medical community, thanks greatly to Dr. Upjohn's marketing strategy. He sent small pine boards to thousands of physicians along with samples of his rival's hard pills, and his own friable pills. He invited doctors to hammer the pills into the boards to see which one would be the most digestible. This tactic was eventually modified, but for the next 60 years, a thumb reducing an Upjohn pill to powder was used as the trademark symbol of his company, the Upjohn Pill and Granule Company, later more widely known to the world as The Upjohn Company. 
  2. VanRheenen, V.; Kelly, R.C.; Cha, D.Y. An improved catalytic OsO4 oxidation of olefins to -1,2-glycols using tertiary amine oxides as the oxidant. Tetrahedron Letters. 1976-06, 17 (23): 1973–1976. doi:10.1016/S0040-4039(00)78093-2. 
  3. 3.0 3.1 ((Lyster, S C.)), ((Duncan, G W.)). ANABOLIC, ANDROGENIC AND MYOTROPIC ACTIVITIES OF DERIVATIVES OF 7α-METHYL-19-NORTESTOSTERONE. Acta Endocrinologica. July 1963, 43 (3): 399–411. doi:10.1530/acta.0.0430399.  溫哥華格式錯誤 (幫助)
  4. ((Castañer, J.)), ((Hillier, K.)). U-23,469. Drugs of the Future. 1980, 5 (11): 564. ISSN 0377-8282. doi:10.1358/dof.1980.005.11.1002363. 

外部連結[編輯]